Skip to content

Efficacy of Erector Spinae Plane (ESP) Block in Patients With Inflammatory Bowel Disease (IBD)

Opioid Use

This will be a prospective, double-blind randomized controlled clinical trial. There will be two arms of treatment: intervention and control group. Preoperatively patients will be allocated at random to receive ultrasound guided bilateral ESP block either with the local anesthetic (intervention group) normal saline (control group). The aim of this study is to examine the effect of ESP block to increase the Quality of Recovery (measured via QoR-15 total score) and decrease opioid consumption.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 to 85

Participation Criteria

Inclusion Criteria:

1. Adults (18-85 years old) diagnosed with IBD
2. ASA physical status I-III
3. IBD abdominal laparoscopic assisted surgeries under general anesthesia

Exclusion Criteria:

1. Unable to communicate in English
2. Unstable requiring emergency surgery
3. Open laparotomies
4. Morbidly obese
5. Pregnant
6. On chronic opioid treatment
7. Known allergies to local anesthetics
8. Altered mental status
9. Concomitant injuries.

Study Location

Mount Sinai Hospital
Mount Sinai Hospital
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Naveed Siddiqui, MD

[email protected]
416-586-5270
Study Sponsored By
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Participants Required
More Information
Study ID: NCT06230003